In addition, a higher incidence of severe neutropenia was observed in patients with homozygous alterations in the liver enzyme uridine diphospho-glucuronyl transferase (UGT1A1) in the ASCENT trial [16,19]. This evidence concerns the gene UGT1A1 and neutropenia.